Cargando…

Gene-expression patterns reveal underlying biological processes in Kawasaki disease

BACKGROUND: Kawasaki disease (KD) is an acute self-limited vasculitis and the leading cause of acquired heart disease in children in developed countries. No etiologic agent(s) has been identified, and the processes that mediate formation of coronary artery aneurysms and abatement of fever following...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popper, Stephen J, Shimizu, Chisato, Shike, Hiroko, Kanegaye, John T, Newburger, Jane W, Sundel, Robert P, Brown, Patrick O, Burns, Jane C, Relman, David A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246263/ https://www.ncbi.nlm.nih.gov/pubmed/18067656 http://dx.doi.org/10.1186/gb-2007-8-12-r261

Ejemplares similares

Unbiased Screening of Kawasaki Disease Sera for Viral Antigen Exposure
por: Quiat, Daniel, et al.
Publicado: (2017)

An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
por: Ghosh, Pradipta, et al.
Publicado: (2022)

Differential Expression of miR-145 in Children with Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2013)

Publisher Correction: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
por: Ghosh, Pradipta, et al.
Publicado: (2022)

Characterization of SARS‐CoV‐2 and common cold coronavirus‐specific T‐cell responses in MIS‐C and Kawasaki disease children
por: Hsieh, Li‐En, et al.
Publicado: (2021)

Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
por: Shimizu, Chisato, et al.
Publicado: (2010)

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
por: Connelly, Margery A., et al.
Publicado: (2016)

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
por: Halyabar, Olha, et al.
Publicado: (2021)

Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
por: Tremoulet, Adriana H., et al.
Publicado: (2015)

Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population
por: Son, Mary Beth F., et al.
Publicado: (2019)

Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G
por: Ogata, Shohei, et al.
Publicado: (2013)

Human Coronavirus NL63 Is Not Detected in the Respiratory Tracts of Children with Acute Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2005)

A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease
por: Whitin, John C., et al.
Publicado: (2016)

Analysis of temporal clusters: A new approach to unraveling the mystery of Kawasaki disease
por: Newburger, Jane W.
Publicado: (2021)

KAWASAKI DISEASE
por: Sundel, Robert P., et al.
Publicado: (2011)

Kawasaki Disease
por: Son, Mary Beth, et al.
Publicado: (2016)

RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2022)

Temporal clustering of Kawasaki disease cases around the world
por: Burney, Jennifer A., et al.
Publicado: (2021)

A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study
por: Lam, Jonathan Y, et al.
Publicado: (2022)

Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
por: Son, Mary Beth F., et al.
Publicado: (2017)

Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction
por: Hoshino, Shinsuke, et al.
Publicado: (2019)

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease
por: Dummer, Kirsten B., et al.
Publicado: (2023)

Finding Kawasaki disease
por: Burns, Jane C
Publicado: (2012)

Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States
por: Burney, Jennifer A., et al.
Publicado: (2022)

Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease
por: Kentsis, Alex, et al.
Publicado: (2013)

Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children
por: Kim, Jihoon, et al.
Publicado: (2023)

Association of Kawasaki disease with tropospheric wind patterns
por: Rodó, Xavier, et al.
Publicado: (2011)

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data
por: Lam, Jonathan Y., et al.
Publicado: (2023)

Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
por: Wright, Victoria J., et al.
Publicado: (2018)

Biomarkers of inflammation and fibrosis in young adults with history of Kawasaki disease()
por: Hoshino, Shinsuke, et al.
Publicado: (2021)

Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms
por: Tedla, Bruke A., et al.
Publicado: (2022)

Myocardial fibrosis in patients with a history of Kawasaki disease
por: Dusenbery, Susan M., et al.
Publicado: (2021)

Temporal Clusters of Kawasaki Disease Cases Share Distinct Phenotypes That Suggest Response to Diverse Triggers
por: Burns, Jane C., et al.
Publicado: (2021)

Idiopathic Pericarditis and Pericardial Effusion in Children: Contemporary Epidemiology and Management
por: Shakti, Divya, et al.
Publicado: (2014)

Management of sequelae of Kawasaki disease in adults
por: Gordon, John B., et al.
Publicado: (2017)

Frequently asked questions regarding treatment of Kawasaki disease
por: Burns, Jane C.
Publicado: (2017)

Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers
por: Rypdal, Martin, et al.
Publicado: (2018)

Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic
por: Harahsheh, Ashraf S., et al.
Publicado: (2020)

Revisiting Once Again Steroids for the Treatment of Acute Kawasaki Disease
por: Burns, Jane C.
Publicado: (2020)

Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease
por: Hoang, Long Truong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rdjknlkbhn0c62b1t52vb0nb70